MORF

Morphic Holding, Inc.

No insider bought or sold Morphic Holding, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow MORF

MORF over the last year

Prices for MORF aren't in yet.

MORF after insider buys

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

134 insider filings since 2019, newest first

MORFSell

Bruce Rogers · President

$1.1M−12.0%Jul 10

MORFSell

Marc Schegerin · CFO and COO

$2.5M−54.0%Jul 10

MORFSell

Praveen P. Tipirneni · President and CEO

$1.2M−34.0%Jul 10

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$1.7M−69.0%Jul 10

MORFSell

William Devaul · General Counsel and Secretary

$558K−30.0%Jul 10

MORFSell

Praveen P. Tipirneni · CEO

$383K−25.0%Jan 17

MORFSell

Marc Schegerin · CFO and COO

$166K−14.0%Jan 17

MORFSell

Bruce Rogers · President

$174K−4.0%Jan 17

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$140K−13.0%Jan 17

MORFSell

William Devaul · General Counsel and Secretary

$124K−16.0%Jan 17

MORFSell

Marc Schegerin · CFO and COO

$1.1M−45.0%Sep 8

MORFSell

Praveen P. Tipirneni · President and CEO

$205K−21.0%Aug 3

MORFSell

Praveen P. Tipirneni · President and CEO

$205K−21.0%Jul 6

MORFSell

Praveen P. Tipirneni · President and CEO

$53K−6.0%Jun 14

MORFSell

William Devaul · General Counsel and Secretary

$466K−37.0%Jun 9

MORFSell

Praveen P. Tipirneni · President and CEO

$206K−21.0%Jun 2

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$600K−30.0%May 25

MORFSell

William Devaul · General Counsel and Secretary

$234K−16.0%May 25

MORFSell

Praveen P. Tipirneni · President and CEO

$184K−21.0%May 5

MORFBuy

Timothy A Springer · Director and 10% owner

$47.3M+16.0%May 4

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$547K−45.0%Apr 27

MORFSell

Praveen P. Tipirneni · President and CEO

$1.3M−64.0%Apr 27

MORFSell

Marc Schegerin · CFO and COO

$2.7M−67.0%Apr 27

MORFSell

Bruce Rogers · President

$1.6M−20.0%Apr 27

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$450K−45.0%Apr 21

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$825K−62.0%Apr 19

MORFSell

Bruce Rogers · President

$403K−8.0%Apr 19

MORFSell

Marc Schegerin · CFO and COO

$2.3M−68.0%Mar 9

MORFSell

Bruce Rogers · President

$401K−8.0%Feb 16

MORFSell

William Devaul · General Counsel and Secretary

$36K−5.0%Jan 18

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$38K−5.0%Jan 18

MORFSell

Bruce Rogers · President

$54K−2.0%Jan 18

MORFSell

Marc Schegerin · CFO and COO

$51K−9.0%Jan 18

MORFSell

Praveen P. Tipirneni · President and CEO

$123K−24.0%Jan 18

MORFSell

Bruce Rogers · Chief Scientific Officer

$410K−9.0%Apr 1

MORFSell

Marc Schegerin · CFO and COO

$329K−29.0%Nov 3

MORFSell

Marc Schegerin · CFO and COO

$1.8M−82.0%Oct 15

MORFSell

Peter Linde · Chief Medical Officer

$266K−26.0%Sep 17

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$840K−56.0%Sep 14

MORFSell

Bruce Rogers · Chief Scientific Officer

$2.5M−31.0%Sep 13

MORFBuy

Timothy A Springer · Director and 10% owner

$4.2M+1.0%Aug 20

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$33K−3.0%Jun 21

MORFSell

Robert E Farrell Jr · SVP Finance, CAO

$1.2M−52.0%Jun 14

MORFSell

Peter Linde · Chief Medical Officer

$299K−57.0%Jun 3

MORFSell

Amir Nashat · Director

$10.6M−10.0%May 25

MORFSell

Omega Fund V, L.P. · Director

$938K−1.0%May 3

MORFSell

Omega Fund V, L.P. · Director

$593K−1.0%Apr 29

MORFSell

Omega Fund V, L.P. · Director

$774K−1.0%Apr 27

MORFSell

Omega Fund V, L.P. · Director

$1.1M−1.0%Apr 23

MORFSell

Omega Fund V, L.P. · Director

$971K−1.0%Apr 21

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.